DISCOUNT ZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000PC4H544

Real-time Boerse Frankfurt Warrants 18:20:14 24/05/2024 BST
282.6 EUR +0.74% Intraday chart for DISCOUNT ZERTIFIKAT - STRYKER CORP.
Current month-1.09%
1 month-0.41%
Date Price Change
24/05/24 282.6 +0.74%
23/05/24 280.6 -0.91%
22/05/24 283.2 +1.20%
21/05/24 279.8 +0.06%
20/05/24 279.6 -0.67%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 06:20 pm

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC4H54
ISINDE000PC4H544
Date issued 02/02/2024
Maturity 19/12/2025 (574 Days)
Parity 1 : 1
Emission price 263.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 289.9
Lowest since issue 275.6
Spread 0.5
Spread %0.18%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.1 USD
Average target price
372.4 USD
Spread / Average Target
+12.79%
Consensus